Zejing Pharmaceuticals: Controlling shareholders and shareholders intend to reduce their combined holdings by no more than 1.04%.

Zejing Pharmaceutical announced that its controlling shareholder, one of the actual controllers, and chairman ZELINSHENG, as well as shareholder Ningbo Zeao, plan to reduce their shareholding due to their own financial needs. ZELINSHENG plans to reduce no more than 273,907 shares, representing 0.1035% of the total share capital; Ningbo Zeao plans to reduce no more than 2,475,090 shares, representing 0.9350% of the total share capital. The reduction period is from March 17 to June 16, 2026, and the reduction method is centralized bidding or block trading. This reduction plan carries uncertainty and will not impact the company's governance structure and ongoing operations.